article thumbnail

Interview with Cody Simmons, CEO of DermaSensor, Maker of Handheld Skin Cancer Evaluation Tool – Xtalks Life Science Podcast Ep. 107

XTalks

He began his career in business development and commercial strategy roles at Genentech. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022. Dermatology. Dermatology. Hear more about the innovative technology and application of DermaSensor in this episode. 2004;208:27-31.

article thumbnail

Spectrum Veterinary Is Now Nextmune–the Global Leader in Specialty Healthcare Dedicated to Healthy, Vibrant Pets for Life

The Pharma Data

Magnus Kjellberg, CEO and co-president, and Gennaro Falanga, co-president, stated: “Over the past few years, we have built up a science-driven, global business spanning 70 worldwide countries dedicated to healthy, vibrant pets for life. We have a particular passion for allergy, dermatology and specialized care, and specialized nutrition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer

The Pharma Data

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. NEW YORK and LONDON, Jan. Dr. Graham earned an M.D.,

article thumbnail

Consumer health innovation – where passion and science meet

pharmaphorum

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.

Allergies 104
article thumbnail

Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units

The Pharma Data

An experienced leader in drug development who has led and grown Lilly’s oncology business over the past several years, White will be responsible for Lilly’s launched products and Phase 3 portfolio in pain and neurodegeneration, including the potential launch of donanemab for the treatment of Alzheimer’s disease.

article thumbnail

Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights Celyad Oncology SA provided an update on its financial results and recent business developments for the fiscal quarter ended September 30, 2022. Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates Valneva SE reported consolidated financial results for the first nine months of the year, ended September 30, 2022. Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update Sol-Gel Technologies, Ltd., a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced financial results for the third quarter ended September 30, 2022 and provided a corporate update. Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference Alvotech announced that it will present two posters and will b

BioSpace

With a fresh $18 million in the bank, NRG Therapeutics is ready to put its novel mitochondrial approach to the test for devastating neurodegenerative disorders—Parkinson’s and ALS.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.